Skip to main content

Aurora Cannabis Inc.

corporate_fare Company Profile

Aurora Cannabis Inc.

ACB·NASDAQ·Life Sciences·CIK 0001683541

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company operates through two segments: Canadian Cannabis and Plant Propagation. It offers pharmaceutical-grade cannabis products, medical and consumer cannabis products, and engages in the propagation of vegetables and floral plants. Its product offerings include dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals. Aurora Cannabis Inc. also provides patient counseling and outreach services. The company's brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC. Its international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc. (NASDAQ:ACB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for ACB at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Aurora Cannabis Reports Strong Q3 Medical Cannabis Growth, Strategic Divestment, and Announces $100M ATM Program
  • Aurora Cannabis Announces $100M ATM Offering and Strategic Divestiture of Bevo Agtech Interest
  • Aurora Advances Cannabis Disease Resistance, Nearing Commercialization of PM-Resistant Cultivars

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
CA$320.59M CAD
Net Income
-CA$135.96M CAD
Diluted EPS
-CA$2.14 CAD
Op. Cash Flow
-CA$13.51M CAD
Free Cash Flow
-CA$36.06M CAD
Gross Profit
CA$136.65M CAD
Cash & Equivalents
CA$64.69M CAD
Total Debt
CA$0 CAD
Debt / Equity
0.00×
Net Margin
-42.4%
Shares Outstanding
58.95M sh
Source: 40-F · filed 2026-06-11 · accession 0001628280-26-042364

Insider Transactions

ACB files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$3.76 +0.02% today
52-week range · as of 2026-09-02 $2.56 – $6.67
Market cap
$243.81M
Volume
94.5K (0.1× avg)
3-mo avg 1.6M
Live data · 2026-09-14 14:30 UTC · Market open

show_chartPrice Chart

Loading chart...

feed ACB - Filings & News (Page 2)

ACB
Feb 04, 2026, 7:27 AM EST
Filing Type: 6-K
Importance Score:
8
Aurora Cannabis Reports Strong Q3 Medical Cannabis Growth, Strategic Divestment, and Announces $100M ATM Program
Price at Filing: $4.04
Real-time Price: $3.76 info
Change: -$0.2799 (-7%) info
Market Cap: $243.811M info
Sentiment: Neutral
View Wiseek Article
ACB
Feb 04, 2026, 7:05 AM EST
Filing Type: 6-K
Importance Score:
8
Aurora Cannabis Announces $100M ATM Offering and Strategic Divestiture of Bevo Agtech Interest
Price at Filing: $4.04
Real-time Price: $3.76 info
Change: -$0.2799 (-7%) info
Market Cap: $243.811M info
Sentiment: Negative
View Wiseek Article
ACB
Jan 14, 2026, 7:22 AM EST
Filing Type: 6-K
Importance Score:
7
Aurora Advances Cannabis Disease Resistance, Nearing Commercialization of PM-Resistant Cultivars
Price at Filing: $4.23
Real-time Price: $3.76 info
Change: -$0.4649 (-11%) info
Market Cap: $243.811M info
Sentiment: Positive
View Wiseek Article
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets